atai Life Sciences to Participate in Upcoming September Investor Conferences
September 06 2023 - 3:01PM
atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage
biopharmaceutical company aiming to transform the treatment of
mental health disorders, will participate in upcoming September
Investor Conferences.
Details of the company’s participation are as follows:
Citi's 18th Annual BioPharma
Conference
Format: 1x1 Only
Date: Thursday, September 7th
Location: Boston, MA
H.C. Wainwright 25th Annual
Global Investment Conference
Format: Fireside Chat
Date and Time: Monday, September 11th
at 4:00 P.M. ET
Location: New York, NY
TD Cowen 3rd Annual Novel
Mechanisms in Neuropsychiatry Summit
Format: Panel
Date and Time: Wednesday, September
20th at 11:00 A.M. ET
Location: Virtual (no webcast)
The webcast for the fireside chat will be available on atai’s
website under Events on the Investors section of the atai website:
https://ir.atai.life/news-events/events/. A replay will be
available following the live event.
About atai Life Sciencesatai is a
clinical-stage biopharmaceutical company aiming to transform the
treatment of mental health disorders and was founded as a response
to the significant unmet need and lack of innovation in the mental
health treatment landscape. atai is dedicated to efficiently
developing innovative therapeutics to treat depression, anxiety,
addiction, and other mental health disorders.
By pooling resources and best practices, atai aims to
responsibly accelerate the development of new medicines to achieve
clinically meaningful and sustained behavioral change in mental
health patients.
atai's vision is to heal mental health disorders so that
everyone, everywhere can live a more fulfilled life. For more
information, please visit www.atai.life.
Contact Information
Investor Contact:IR@atai.life
Media Contact:PR@atai.life
ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From May 2024 to Jun 2024
ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From Jun 2023 to Jun 2024